Doxorubicin: all 842 studies that test it
Page 7 of 9. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.
- A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue SarcomaTerminatedNCT00718484Phase 2
- A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With BortezomibWithdrawnNCT00706953Phase 2
- Phase I Study of DOXIL and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703170Phase 1
- Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal DoxorubicinTerminatedNCT00691912Phase 2
- Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade OsteosarcomaStatus unknownNCT00691236Phase 2/3
- Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing SurgeryStatus unknownNCT00671476Not applicable
- Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer PatientStatus unknownNCT00669773Phase 2
- CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based ChemotherapyTerminatedNCT00653952Phase 3
- Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerTerminatedNCT00635726Phase 2
- Phase II Study of Valproate and Doxorubicin in Malignant MesotheliomaCompletedNCT00634205Phase 2
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00613457Phase 3
- Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing RegimensWithdrawnNCT00610792Phase 2
- Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid TumorsCompletedNCT00608803Phase 1
- Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
- Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell LymphomaCompletedNCT00575406Phase 2
- Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 YearsCompletedNCT00563953Phase 2
- Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian CancerWithdrawnNCT00562185Phase 1/2
- A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma PatientsCompletedNCT00561743Phase 2
- PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneCompletedNCT00544219Not applicable
- German Preoperative Adriamycin Docetaxel StudyCompletedNCT00543829Phase 2
- Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)CompletedNCT00538603Not applicable
- Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast CancerCompletedNCT00538525Not applicable
- Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast CancerStatus unknownNCT00538395Not applicable
- A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler ImagingStatus unknownNCT00531973Phase 4
- The Magnetic Resonance Imaging Evaluation of Doxorubicin CardiotoxicityCompletedNCT00530101Phase 1
- Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian CancerCompletedNCT00523380Phase 2
- Phase II Study in Patients With Operable Breast CancerStatus unknownNCT00518583Phase 2
- Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and CisplatinTerminatedNCT00516750Phase 2
- Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast CancerStatus unknownNCT00516425Phase 3
- A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple MyelomaWithdrawnNCT00516191Phase 1/2
- PVAG-14 Pilot for Intermediate Stages Hodgkin LymphomaTerminatedNCT00512980Phase 2
- Primary Breast Cancer Occurring Concomitant With PregnancyCompletedNCT00510367Early Phase 1
- Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver InvolvementCompletedNCT00507962Phase 1
- Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue SarcomaCompletedNCT00502411Phase 1
- Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer PatientsCompletedNCT00500422Phase 1
- Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal CarcinomaTerminatedNCT00484601Phase 2
- Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian CancerCompletedNCT00484432Phase 2
- Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.CompletedNCT00484341Phase 2
- Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid TumorsCompletedNCT00479128Phase 1
- Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast CancerTerminatedNCT00465673Phase 2
- Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerTerminatedNCT00461344Phase 2
- CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's LymphomaTerminatedNCT00455897Phase 2
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
- CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast CancerWithdrawnNCT00434031Phase 2
- Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast CancerTerminatedNCT00431795Phase 2
- Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryCompletedNCT00424203Phase 2
- Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00416533Phase 2
- Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue SarcomaStatus unknownNCT00410462Phase 2
- Bortezomib-Dexamethasone-Doxorubicin-StudyCompletedNCT00401804Phase 2
- END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal DoxorubicinCompletedNCT00401635Phase 2
- Combination Chemotherapy in Treating Young Male Patients With Hodgkin's LymphomaCompletedNCT00398554Phase 2
- Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 NeuroblastomaStatus unknownNCT00392340Phase 2
- PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue SarcomaCompletedNCT00346125Not applicable
- EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in ChildrenStatus unknownNCT00339118Phase 4
- Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue SarcomaStatus unknownNCT00334854Phase 3
- A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.Status unknownNCT00333008Phase 2
- Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid TumorsCompletedNCT00331955Phase 1
- MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian CancerStatus unknownNCT00326456Phase 3
- CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell LymphomasCompletedNCT00323323Phase 1
- PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple MyelomaStatus unknownNCT00319865Phase 2
- Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast CancerCompletedNCT00316875Phase 1
- Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.CompletedNCT00314977Phase 3
- AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast CancerCompletedNCT00310089Not applicable
- Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast CancerTerminatedNCT00296010Phase 3
- Trial of Myocet in Metastatic Breast CancerStatus unknownNCT00294996Phase 3
- Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)CompletedNCT00288431Phase 1
- Caelyx Adjuvant in Elderly Breast CancerCompletedNCT00284336Phase 2
- Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and IfosfamideCompletedNCT00283621Not applicable
- Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00278421Phase 3
- Doxil Topotecan Doublet Cancer StudyCompletedNCT00252889Phase 1
- Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast CancerStatus unknownNCT00250874Phase 2
- DOXIL for Consolidation Therapy in Ovarian Cancer.CompletedNCT00248248Phase 2
- Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.Status unknownNCT00244127Phase 2
- Combination Chemotherapy +/- Radiation in High Risk Hodgkin's DiseaseTerminatedNCT00225173Phase 2
- Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based ChemotherapyCompletedNCT00216645Phase 2
- Gene Expression Profiles in Predicting Chemotherapy Response in Breast CancerCompletedNCT00212082Phase 2
- Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's LymphomaCompletedNCT00210379Phase 2
- Biologic Correlative Taxotere/ACCompletedNCT00206466Phase 2
- Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)CompletedNCT00204646Phase 2
- Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast CancerCompletedNCT00201708Phase 2
- Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple MyelomaCompletedNCT00201695Phase 2
- Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in AdultsCompletedNCT00199082Phase 4
- German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)CompletedNCT00198991Phase 4
- Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast CancerCompletedNCT00193115Phase 2
- Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late RelapseCompletedNCT00189553Phase 3
- Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic TumoursCompletedNCT00189410Phase 2
- Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHLCompletedNCT00187161Phase 2
- Large Cell Lymphoma Pilot Study IIICompletedNCT00187070Not applicable
- Study for Treatment of Cancer in Children With Ataxia-telangiectasiaCompletedNCT00187057Not applicable
- Therapy for Children With Advanced Stage High Risk NeuroblastomaCompletedNCT00186849Phase 2
- Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's LymphomasTerminatedNCT00183976Phase 2
- Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)CompletedNCT00183742Phase 1
- Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal CarcinomaTerminatedNCT00179725Phase 1/2
- Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate CancerTerminatedNCT00176293Phase 2
- Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or EsophagusCompletedNCT00165191Phase 2
- The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine SarcomasStatus unknownNCT00162721Phase 3
- LAMPP Trial for Peripheral and Cutaneous T-Cell LymphomaTerminatedNCT00161239Not applicable
- A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast CancerStatus unknownNCT00159094Phase 2
- Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's LymphomaCompletedNCT00147875Phase 1/2
- Osteosarcoma1999-A Study Of Intensive Chemotherapy for OsteosarcomaCompletedNCT00145639Phase 2